Skip to main content
Log in

Synchronous glioblastoma and medulloblastoma in a child with mismatch repair mutation

  • Case Report
  • Published:
Child's Nervous System Aims and scope Submit manuscript

Abstract

Synchronous primary malignant brain tumors are rare. We present a 5-year-old boy with synchronous glioblastoma and medulloblastoma. Both tumor samples had positive p53 stain and loss of PMS2 and MLH1 stains. The child had multiple café au lait spots and a significant family history of cancer. After subtotal resection of both tumors, he received craniospinal radiation with concomitant temozolomide followed by chemotherapy, alternating cycles of cisplatin/lomustine/vincristine with temozolomide. Then, he started maintenance treatment with cis-retinoic acid (100 mg/m2/day for 21 days). He remained asymptomatic for 34 months despite a follow-up brain MRI consistent with glioblastoma relapse 9 months before his death. Cis-retinoic acid may have contributed to prolong survival in this child with a probable biallelic mismatch repair syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Gajjar A, Chintagumpala M, Ashley D, Kellie S, Kun LE, Merchant TE, Woo S, Wheeler G, Ahern V, Krasin MJ, Fouladi M, Broniscer A, Krance R, Hale GA, Stewart CF, Dauser R, Sanford RA, Fuller C, Lau C, Boyett JM, Wallace D, Gilbertson RJ (2006) Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol 7:813–820

    Article  PubMed  Google Scholar 

  2. Cohen KJ, Pollack IF, Zhou T, Buxton A, Holmes EJ, Burger PC, Brat DJ, Rosenblum MK, Hamilton RL, Lavey RS, Heideman RL (2011) Temozolomide in the treatment of high-grade gliomas in children: a report from the Children’s Oncology Group. Neuro-Oncology 13:317–323

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Wimmer K, Kratz CP, Vasen HF, Caron O, Colas C, Entz-Werle N, Gerdes AM, Goldberg Y, Ilencikova D, Muleris M, Duval A, Lavoine N, Ruiz-Ponte C, Slavc I, Burkhardt B, Brugieres L (2014) Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European Consortium ‘care for CMMRD’ (C4CMMRD). J Med Genet 51:355–365

    Article  CAS  PubMed  Google Scholar 

  4. Vasen HF, Ghorbanoghli Z, Bourdeaut F, Cabaret O, Caron O, Duval A, Entz-Werle N, Goldberg Y, Ilencikova D, Kratz CP, Lavoine N, Loeffen J, Menko FH, Muleris M, Sebille G, Colas C, Burkhardt B, Brugieres L, Wimmer K (2014) Guidelines for surveillance of individuals with constitutional mismatch repair-deficiency proposed by the European Consortium “Care for CMMR-D” (C4CMMR-D). J Med Genet 51:283–293

    Article  CAS  PubMed  Google Scholar 

  5. Bakry D, Aronson M, Durno C, Rimawi H, Farah R, Alharbi QK, Alharbi M, Shamvil A, Ben-Shachar S, Mistry M, Constantini S, Dvir R, Qaddoumi I, Gallinger S, Lerner-Ellis J, Pollett A, Stephens D, Kelies S, Chao E, Malkin D, Bouffet E, Hawkins C, Tabori U (2014) Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: report from the constitutional mismatch repair deficiency consortium. Eur J Cancer 50:987–996

    Article  PubMed  Google Scholar 

  6. Jea A, Coscarella E, Chintagumpala M, Bhattacharjee M, Whitehead WE, Curry DJ, Luerssen TG (2010) Medulloblastoma and juvenile pilocytic astrocytoma presenting as synchronous primary brain tumors in a child: case report. J Neurosurg Pediatr 5:149–154

    Article  PubMed  Google Scholar 

  7. Bhangui GR, Roy S, Tandon PN (1977) Multiple primary tumors of the brain including a medulloblastoma in the cerebellum. Cancer 39:293–297

    Article  CAS  PubMed  Google Scholar 

  8. Karami KJ, Poulik J, Rabah R, Krass J, Sood S (2010) Simultaneous choroid plexus carcinoma and pilocytic astrocytoma in a pediatric patient. J Neurosurg Pediatr 5:104–112

    Article  PubMed  Google Scholar 

  9. Schniederjan MJ, Shehata B, Brat DJ, Esiashvili N, Janss AJ (2009) De novo germline TP53 mutation presenting with synchronous malignancies of the central nervous system. Pediatr Blood Cancer 53:1352–1354

    Article  PubMed  Google Scholar 

  10. McLaughlin MR, Gollin SM, Lese CM, Albright AL (1998) Medulloblastoma and glioblastoma multiforme in a patient with Turcot syndrome: a case report. Surg Neurol 49:295–301

    Article  CAS  PubMed  Google Scholar 

  11. Takeshi N, Kazuhiko S, Koji I, Toshikazu H, Kaoru K (2013) A case of adult onset medulloblastoma during maintenance chemotherapy for anaplastic astrocytoma one year after radiotherapy. Turk Neurosurg 23:521–526

    PubMed  Google Scholar 

  12. Amayiri N, Tabori U, Campbell B, Bakry D, Aronson M, Durno C, Rakopoulos P, Malkin D, Qaddoumi I, Musharbash A, Swaidan M, Bouffet E, Hawkins C, Al-Hussaini M (2015) High frequency of mismatch repair deficiency among pediatric high grade gliomas in Jordan. Int J Cancer. doi:10.1002/ijc.29724

  13. Durno CA, Aronson M, Tabori U, Malkin D, Gallinger S, Chan HS (2012) Oncologic surveillance for subjects with biallelic mismatch repair gene mutations: 10 year follow-up of a kindred. Pediatr Blood Cancer 59:652–656

    Article  PubMed  Google Scholar 

  14. Fink D, Aebi S, Howell SB (1998) The role of DNA mismatch repair in drug resistance. Clin Cancer Res: Off J Am Assoc Cancer Res 4:1–6

    CAS  Google Scholar 

  15. McFaline-Figueroa JL, Braun CJ, Stanciu M, Nagel ZD, Mazzucato P, Sangaraju D, Cerniauskas E, Barford K, Vargas A, Chen Y, Tretyakova N, Lees JA, Hemann MT, White FM, Samson LD (2015) Minor changes in expression of the mismatch repair protein MSH2 exert a major impact on glioblastoma response to temozolomide. Cancer Res 75:3127–3138

    Article  CAS  PubMed  Google Scholar 

  16. Brown KD, Rathi A, Kamath R, Beardsley DI, Zhan Q, Mannino JL, Baskaran R (2003) The mismatch repair system is required for S-phase checkpoint activation. Nat Genet 33:80–84

    Article  CAS  PubMed  Google Scholar 

  17. Cejka P, Stojic L, Marra G, Jiricny J (2004) Is mismatch repair really required for ionizing radiation-induced DNA damage signaling? Nat Genet 36:432–433, author reply 434

    Article  CAS  PubMed  Google Scholar 

  18. Masetti R, Biagi C, Zama D, Vendemini F, Martoni A, Morello W, Gasperini P, Pession A (2012) Retinoids in pediatric onco-hematology: the model of acute promyelocytic leukemia and neuroblastoma. Adv Ther 29:747–762

    Article  CAS  PubMed  Google Scholar 

  19. Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK, Swift P, Shimada H, Black CT, Brodeur GM, Gerbing RB, Reynolds CP (1999) Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children’s Cancer Group N Engl J Med 341:1165–1173

    Article  CAS  PubMed  Google Scholar 

  20. Das A, Banik NL, Ray SK (2008) Retinoids induced astrocytic differentiation with down regulation of telomerase activity and enhanced sensitivity to taxol for apoptosis in human glioblastoma T98G and U87MG cells. J Neuro-Oncol 87:9–22

    Article  CAS  Google Scholar 

  21. Liang C, Guo S, Yang L (2013) All-trans retinoic acid upregulates VEGF expression in glioma cells in vitro. J Biomed Res 27:51–55

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Ying M, Wang S, Sang Y, Sun P, Lal B, Goodwin CR, Guerrero-Cazares H, Quinones-Hinojosa A, Laterra J, Xia S (2011) Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition. Oncogene 30:3454–3467

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Karsy M, Albert L, Tobias ME, Murali R, Jhanwar-Uniyal M (2010) All-trans retinoic acid modulates cancer stem cells of glioblastoma multiforme in an MAPK-dependent manner. Anticancer Res 30:4915–4920

    CAS  PubMed  Google Scholar 

  24. Jaeckle KA, Hess KR, Yung WK, Greenberg H, Fine H, Schiff D, Pollack IF, Kuhn J, Fink K, Mehta M, Cloughesy T, Nicholas MK, Chang S, Prados M (2003) Phase II evaluation of temozolomide and 13-cis-retinoic acid for the treatment of recurrent and progressive malignant glioma: a North American Brain Tumor Consortium study. J Clin Oncol: Off J Am Soc Clin Oncol 21:2305–2311

    Article  CAS  Google Scholar 

  25. Grauer O, Pascher C, Hartmann C, Zeman F, Weller M, Proescholdt M, Brawanski A, Pietsch T, Wick W, Bogdahn U, Hau P (2011) Temozolomide and 13-cis retinoic acid in patients with anaplastic gliomas: a prospective single-arm monocentric phase-II study (RNOP-05). J Neuro-Oncol 104:801–809

    Article  CAS  Google Scholar 

  26. Gottschling S, Reinhard H, Pagenstecher C, Kruger S, Raedle J, Plotz G, Henn W, Buettner R, Meyer S, Graf N (2008) Hypothesis: possible role of retinoic acid therapy in patients with biallelic mismatch repair gene defects. Eur J Pediatr 167:225–229

    Article  PubMed  Google Scholar 

  27. Bai R, Siu IM, Tyler BM, Staedtke V, Gallia GL, Riggins GJ (2010) Evaluation of retinoic acid therapy for OTX2-positive medulloblastomas. Neuro-Oncology 12:655–663

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Chemotherapy and radiation therapy in treating young patients with newly diagnosed, previously untreated, high-risk medulloblastoma. https://clinicaltrials.gov/ct2/show/NCT00392327?term=ACNS0332&rank=1. Accessed 10 Jan 2013

  29. Hamilton SR, Liu B, Parsons RE, Papadopoulos N, Jen J, Powell SM, Krush AJ, Berk T, Cohen Z, Tetu B, Burger PC,Wood PA, Taqi F, Booker SV, Petersen GM,Offerhaus G, Johan A, Tersmette AC, Giardiello FM, Vogelstein B, Kinzler KW (1995) The molecular basis of Turcot’s syndrome. N Engl J Med 332:839–847

Download references

Acknowledgments

We thank the family of this lovely child for their tremendous care and for allowing us to take care of him.

Conflict of interest

The authors declare that they have no competing interests.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nisreen Amayiri.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Amayiri, N., Al-Hussaini, M., Swaidan, M. et al. Synchronous glioblastoma and medulloblastoma in a child with mismatch repair mutation. Childs Nerv Syst 32, 553–557 (2016). https://doi.org/10.1007/s00381-015-2883-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00381-015-2883-3

Keywords

Navigation